608 related articles for article (PubMed ID: 18593321)
1. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
[TBL] [Abstract][Full Text] [Related]
2. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma.
Wiley JL; Rook KA; Clifford CA; Gregor TP; Sorenmo KU
Vet Comp Oncol; 2010 Sep; 8(3):221-33. PubMed ID: 20691029
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992).
McNiel EA; Ogilvie GK; Powers BE; Hutchison JM; Salman MD; Withrow SJ
J Am Vet Med Assoc; 1997 Dec; 211(11):1422-7. PubMed ID: 9394893
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.
Skorupski KA; Rodriguez CO; Krick EL; Clifford CA; Ward R; Kent MS
Vet Comp Oncol; 2009 Jun; 7(2):139-44. PubMed ID: 19453368
[TBL] [Abstract][Full Text] [Related]
7. Hemangiosarcoma in cats: 53 cases (1992-2002).
Johannes CM; Henry CJ; Turnquist SE; Hamilton TA; Smith AN; Chun R; Tyler JW
J Am Vet Med Assoc; 2007 Dec; 231(12):1851-6. PubMed ID: 18081524
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Stanclift RM; Gilson SD
J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
[TBL] [Abstract][Full Text] [Related]
9. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
[TBL] [Abstract][Full Text] [Related]
10. Surgery and doxorubicin in dogs with hemangiosarcoma.
Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ
J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871
[TBL] [Abstract][Full Text] [Related]
11. Primary rib tumors in 54 dogs.
Pirkey-Ehrhart N; Withrow SJ; Straw RC; Ehrhart EJ; Page RL; Hottinger HL; Hahn KA; Morrison WB; Albrecht MR; Hedlund CS
J Am Anim Hosp Assoc; 1995; 31(1):65-9. PubMed ID: 7820767
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004).
Boston SE; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2006 Jun; 228(12):1905-8. PubMed ID: 16784383
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
14. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
Finotello R; Stefanello D; Zini E; Marconato L
Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994
[TBL] [Abstract][Full Text] [Related]
15. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.
Teske E; Rutteman GR; Kirpenstein J; Hirschberger J
Vet Comp Oncol; 2011 Dec; 9(4):283-9. PubMed ID: 22077409
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of radiotherapy alone or in combination with doxorubicin chemotherapy for the treatment of cats with incompletely excised soft tissue sarcomas: 71 cases (1989-1999).
Hahn KA; Endicott MM; King GK; Harris-King FD
J Am Vet Med Assoc; 2007 Sep; 231(5):742-5. PubMed ID: 17764436
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003).
Rassnick KM; Goldkamp CE; Erb HN; Scrivani PV; Njaa BL; Gieger TL; Turek MM; McNiel EA; Proulx DR; Chun R; Mauldin GE; Phillips BS; Kristal O
J Am Vet Med Assoc; 2006 Aug; 229(3):401-6. PubMed ID: 16881833
[TBL] [Abstract][Full Text] [Related]
19. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
Morales-Vásquez F; Gonzalez-Angulo AM; Broglio K; Lopez-Basave HN; Gallardo D; Hortobagyi GN; De La Garza JG
Breast J; 2007; 13(6):551-6. PubMed ID: 17983394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
